Fierce BioBiotech
AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs
21 Apr 20260 views
Summary
Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his days in his backyard, sketching out designs for new antibody-drug conjugates with a friend. Now, he’s sharing with the world the result of those complicated doodles: a biotech startup with a focus on “smart” cancer drugs.
Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his days in his backyard, sketching out designs for new antibody-drug conjugates with a friend. Now, he’s sharing with the world the result of those complicated doodles: a biotech startup with a focus on “smart” cancer drugs.